Advances in the diagnostics and therapy of neonatal sepsis;Nye muligheter for diagnostikk og behandling ved neonatal sepsis

Tidsskrift for den Norske Laegeforening

Volumn 117, Issue 27, 1997, Pages 3957-3960

  Hogåsen, Akm ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIBODY; ANTIINFLAMMATORY AGENT; COLONY STIMULATING FACTOR; CORTICOSTEROID; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; MONOCLONAL ANTIBODY; NITRIC OXIDE SYNTHASE INHIBITOR; PENTOXIFYLLINE; PROSTAGLANDIN SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

HUMAN; NEWBORN; NEWBORN SEPSIS; SHORT SURVEY;

ADJUVANTS, IMMUNOLOGIC; ANTI-BACTERIAL AGENTS; HUMANS; INFANT, NEWBORN; SEPSIS; SHOCK, SEPTIC;

EID: 0030725622     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (21)

1. Siegel JD, McCracken GH jr. Sepsis neonatorum. N Engl J Med 1981; 304: 642-7.
2. Hals J, Lindemann R. Tidlig neonatal septikemi. Tidsskr Nor Lægeforen 1987; 107: 1228-30.
3. Anderson MR, Blumer JL. Advances in the therapy for sepsis in children. Pediatr Clin North Am 1997; 44: 179-205.
4. Klein JO, Marcy SM. Bacterial sepsis and meningitis. I: Remington JS, Klein JO, red. Infectious diseases of the fetus and newborn infant Philadelphia: Saunders, 1990: 601-56.
5. Wilson CB. Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr 1986; 108: 1-12.
6. Johnston RB jr., Altenburger KM, Atkinson AW jr., Curry RH. Complement in the newborn infant. Pediatrics 1979; 64 (suppl 2): 781-6.
7. Abrahamsen TG, Gaustad P, Sund S, Hansen TWR. Disseminerte soppinfeksjoner hos nyfoødte - risikofaktorer, behandling og forlop. Tidsskr Nor Lægeforen 1992; 112: 3548-51.
8. Zilow G, Zilow EP, Burger R, Linderkamp O. Complement activation in newborn infants with early onset infection. Pediatr Res 1993; 34-199-203.
9. Buck C, Bundschu J, Gallati H, Bartmann P, Pohlandt F. Interleukin-6: a sensitive parameter for the early diagnosis of neonatal bacterial infection. Pediatrics 1994; 93: 54-8.
10. Kennon C, Overturf G, Bessman S, Sierra E, Smith KJ, Brann B. Granulocyte colony-stimulating factor as a marker for bacterial infection in neonates. J Pediatr 1996; 128: 765-9.
11. Fanaroff AA, Korones SB, Wright LL, Wright EC, Poland RL, Bauer CB et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. N Engl J Med 1994; 330: 1107-13.
12. Hill HR. Intravenous immunoglobulin use in the neonate: role in prophylaxis and therapy of infection. Pediatr Infect Dis J 1993; 12: 549-58.
13. Weisman LE, Stoll BJ, Kueser TJ, Rubio TT, Frank CG, Heiman HS et al. Intravenous immune globulin therapy for early-onset sepsis in premature neonates. J Pediatr 1992; 121: 434-43.
14. Cairo MS, Plunkett JM, Nguyen A, van de Yen C. Effect of stem cell factor with and without granulocyte colony-stimulating factor on neonatal hematopoiesis: in vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis. Blood 1992; 80: 96-101.
15. Cairo MS, Plunkett JM, Mauss D, van de Ven C. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis. Blood 1990; 76: 1788-94.
16. Wheeler JG, Givner LB. Therapeutic use of recombinant human granulocyte-macrophage colony-stimulating factor in neonatal rats with type III group B streptococcal sepsis. J Infect Dis 1992; 165: 938-41.
17. Nankervis CA, Seguin JH. Granulocyte colony-stimulating factor for neutropenia in neonatal sepsis. Arch Pediatr Adolesc Med 1995; 149: 218-9.
18. Gillan ER, Christensen RD, Suen Y, Ellis R, van de Yen C, Cairo MS. A randomized, placebocontrolled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood 1994; 84: 1427-33.
19. Cairo MS, Christensen R, Sender LS, Ellis R, Rosenthal J, van de Yen C et al. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils. Blood 1995; 86: 2509-15.
20. Givner LB, Gray L, O'Shea TM. Antibodies to tumor necrosis factor-alpha: use as adjunctive therapy in established group B streptococcal disease in newborn rats. Pediatr Res 1995; 38: 551-4.
21. Lauterbach R, Zembala M. Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis. Eur J Pediatr 1996; 155: 404-9.